iVision Tech Future Growth
Future criteria checks 0/6
iVision Tech's revenue is forecast to decline at 96.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 19.0% |
| Revenue growth rate | -96.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Oct 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 25 | N/A | 2 | 3 | 1 |
| 12/31/2025 | 19 | N/A | 1 | 2 | 1 |
| 12/31/2024 | 14 | N/A | 0 | 1 | 1 |
| 12/31/2023 | 11 | N/A | -2 | 1 | 1 |
| 6/30/2023 | 10,724 | 590 | -1,757 | 577 | N/A |
| 3/31/2023 | 10,111 | 436 | -1,658 | 129 | N/A |
| 12/31/2022 | 9,497 | 282 | -1,558 | -319 | N/A |
| 12/31/2021 | 4,751 | 77 | -4,817 | -2,906 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if IVN's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if IVN's earnings are forecast to grow faster than the Italian market
High Growth Earnings: Insufficient data to determine if IVN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IVN's revenue is expected to decline over the next 3 years (-96.7% per year).
High Growth Revenue: IVN's revenue is forecast to decline over the next 3 years (-96.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IVN's Return on Equity is forecast to be high in 3 years time